Zobrazeno 1 - 6
of 6
pro vyhledávání: '"kagan Ege Karakus"'
Publikováno v:
JBMR Plus, Vol 7, Iss 11, Pp n/a-n/a (2023)
ABSTRACT Monogenic diabetes, including mitochondrial diabetes, constitutes 1% to 3% of all diabetes. Although there is an increased interest in understanding the mechanisms of bone fragility in people with diabetes, skeletal research is mostly focuse
Externí odkaz:
https://doaj.org/article/25617859392c40a3a89baf24a5adae68
Autor:
Şükrü Hatun, Tuğba Gökçe, Ecem Can, Elif Eviz, Kağan Ege Karakuş, Carmel Smart, Ragnar Hanas, Gül Yeşiltepe Mutlu
Publikováno v:
JCRPE, Vol 16, Iss 3, Pp 245-255 (2024)
Successful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycemic values, quality
Externí odkaz:
https://doaj.org/article/8ee2b919b7be4df281dc8c156a67c9b4
Autor:
Zahra Omidian, Thomas Donner, Sarah M Omer, Neha Majety, Abdel Rahim A. Hamad, Adebola Giwa, Kagan Ege Karakus, Rizwan Ahmed
Publikováno v:
World Journal of Diabetes
Type 1 diabetes (T1D) is an autoimmune disease that usually strikes early in life, but can affect individuals at almost any age. It is caused by autoreactive T cells that destroy insulin-producing beta cells in the pancreas. Epidemiological studies e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baae65a14aec9f9cbcf225fc4e4a63e2
http://europepmc.org/articles/PMC6927819
http://europepmc.org/articles/PMC6927819
Autor:
Mehmet Kanbay, Kagan Ege Karakus, Baris Afsar, Mads Hornum, Peter Rossing, Pantelis Sarafidis, Adrian Covic, Alberto Ortiz, Atalay Demiray
Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are promising drugs to treat chronic kidney disease patients with or without diabetes mellitus (DM). Besides improving glycemic control, SGLT2i are cardioprotective and kidney protective and dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adab1383d816a02dd443817418a44008
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94637
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94637
Autor:
Rizwan Ahmed, Zahra Omidian, Adebola Giwa, Kusuma Ananth, kagan Ege Karakus, Mahamoud Aljack, Neha Majety, Angela Yang, Alana Macdonald, Sanjana Tyagi, Hao Zhang, Hamid Rabb, Chunfa Jie, Thomas Donner, Abdel Hamad
Publikováno v:
The Journal of Immunology. 206:21.03-21.03
PURPOSE: We have recently identified a previously unknown lymphocyte that is a dual expresser (DE) of productively rearranged and surface-expressed TCRαβ and BCR (surface immunoglobulin, Ig) (Ahmed et al, Cell, 2019: 177:11583). Importantly, a sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e88d948a0611b6b1fb40be8ea22b67ad
https://doi.org/10.4049/jimmunol.206.supp.21.03
https://doi.org/10.4049/jimmunol.206.supp.21.03
Autor:
Kağan Ege Karakuş, Sibel Sakarya MD, MPH, Gül Yeşiltepe Mutlu MD, Metehan Berkkan, Serra Muradoğlu MA, Ecem Can MSN, RN, Tuğba Gökçe BSN, Elif Eviz MD, Şükrü Hatun MD
Publikováno v:
Journal of Patient Experience, Vol 8 (2021)
Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted w
Externí odkaz:
https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b